Back to
UBS Group AG
FATE30 quarters
Position history for
UBS Group AG's holdings in FATE THERAPEUTICS INC
UBS Group AG holds 590,178 shares of FATE (FATE THERAPEUTICS INC), worth $1.6M as of 2026-Q2. The position was decreased (-67.6% shares). FATE represents 0.0% of UBS Group AG's portfolio.
Current Value
$1.6M
Current Shares
590,178
Total Value Change
+$1.4M
Total Shares Change
+580,624
Quarter-by-Quarter History
Other major holders of FATE: BNP PARIBAS FINANCIAL MARKETS, ARK Investment Management LLC